Wnt3a is the most commonly studied agonist of the canonical Wnt signaling pathway and that is why it was selected to be included in the kit. Wnt3a included in this kit is only intended for use as a positive control. In the eventuality that you need more of the Wnt3a agonist for your specific requirements, recombinant Wnt3a (ENZ-60001) is available as a stand-alone product. 

Leave a comment